- Home
- DRIO vs ALGS Comparison
DRIO vs ALGS Comparison
Compare DRIO & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRIO
- ALGS
- Stock Information
- Founded
- DRIO 2011
- ALGS 2018
- Country
- DRIO United States
- ALGS United States
- Employees
- DRIO N/A
- ALGS N/A
- Industry
- DRIO Medical/Dental Instruments
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- DRIO Health Care
- ALGS Health Care
- Exchange
- DRIO Nasdaq
- ALGS Nasdaq
- Market Cap
- DRIO 25.1M
- ALGS 23.5M
- IPO Year
- DRIO N/A
- ALGS 2020
- Fundamental
- Price
- DRIO $0.81
- ALGS $18.21
- Analyst Decision
- DRIO Strong Buy
- ALGS Strong Buy
- Analyst Count
- DRIO 1
- ALGS 1
- Target Price
- DRIO $4.00
- ALGS $75.00
- AVG Volume (30 Days)
- DRIO 62.2K
- ALGS 448.4K
- Earning Date
- DRIO 11-07-2024
- ALGS 11-06-2024
- Dividend Yield
- DRIO N/A
- ALGS N/A
- EPS Growth
- DRIO N/A
- ALGS N/A
- EPS
- DRIO N/A
- ALGS N/A
- Revenue
- DRIO $23,052,000.00
- ALGS $5,997,000.00
- Revenue This Year
- DRIO $36.66
- ALGS N/A
- Revenue Next Year
- DRIO $35.35
- ALGS N/A
- P/E Ratio
- DRIO N/A
- ALGS N/A
- Revenue Growth
- DRIO N/A
- ALGS N/A
- 52 Week Low
- DRIO $0.71
- ALGS $6.76
- 52 Week High
- DRIO $2.60
- ALGS $30.00
- Technical
- Relative Strength Index (RSI)
- DRIO 34.82
- ALGS 66.43
- Support Level
- DRIO $0.84
- ALGS $9.02
- Resistance Level
- DRIO $0.95
- ALGS $21.89
- Average True Range (ATR)
- DRIO 0.07
- ALGS 2.02
- MACD
- DRIO -0.01
- ALGS 1.04
- Stochastic Oscillator
- DRIO 7.18
- ALGS 57.04
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.